egtazic acid has been researched along with psychosine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Noble, EP; Ritchie, T; Rosenberg, A | 1 |
Bischoff, A; Czyborra, P; Fetscher, C; Jakobs, KH; Meyer Zu Heringdorf, D; Michel, MC | 1 |
Assmann, G; Fobker, M; Höbbel, G; Junker, R; Nofer, JR; Seedorf, U; Tepel, M; von Eckardstein, A; Voss, R; Walter, M; Wolinska, I; Zidek, W | 1 |
3 other study(ies) available for egtazic acid and psychosine
Article | Year |
---|---|
Regulation of phosphoinositide hydrolysis in cultured astrocytes by sphingosine and psychosine.
Topics: Alkaloids; Animals; Animals, Newborn; Astrocytes; Brain; Calcium; Cells, Cultured; Egtazic Acid; Hydrolysis; Inositol Phosphates; Kinetics; Norepinephrine; Phosphatidylinositols; Protein Kinase C; Psychosine; Rats; Sphingosine; Staurosporine | 1992 |
Sphingosine-1-phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitro.
Topics: Animals; Calcium; Dose-Response Relationship, Drug; Egtazic Acid; In Vitro Techniques; Indomethacin; Lysophospholipids; Male; Mesenteric Arteries; Nitrendipine; Nitroarginine; Pertussis Toxin; Phosphorylcholine; Psychosine; Rats; Rats, Wistar; Renal Artery; Sphingosine; Vasoconstriction; Vasodilator Agents; Virulence Factors, Bordetella | 2000 |
Activation of phosphatidylinositol-specific phospholipase C by HDL-associated lysosphingolipid. Involvement in mitogenesis but not in cholesterol efflux.
Topics: Apolipoprotein A-I; Calcium Signaling; Cells, Cultured; Cholesterol; DNA; Egtazic Acid; Enzyme Activation; Estrenes; Fibroblasts; Humans; Lipoproteins, HDL; Lysophospholipids; Mitogens; Nickel; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositol Diacylglycerol-Lyase; Phosphoinositide Phospholipase C; Phosphorylcholine; Psychosine; Pyrrolidinones; Sphingolipids; Sphingosine; Tangier Disease; Type C Phospholipases | 2000 |